Bioventix plc (BVXP) Ordinary 5p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Bioventix revenue rises in tougher first half
29 March 2021 08:58
(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.
-
Bioventix appoints Bruce Hiscox as chief financial officer
1 July 2020 09:40
(Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
-
Bioventix full-year revenue and profits improve
21 October 2019 11:33
(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, reported a 6% improvement in revenue...
-
Vitamin D antibodies drive first-half growth at Bioventix
29 March 2019 08:31
(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.
-
Bioventix posts healthy profits, ups dividend; warns of plateauing vit-D sales
8 October 2018 12:09
(Sharecast News) - Aim's Bioventix announced Monday it would pay a special dividend after a strong year of revenue and profit growth - but also sounded a warning over one of its key revenue streams.
Company announcements Announcements
-
Half-year Report
29 March 2021 07:00
Bioventix
-
Price Monitoring Extension
25 February 2021 16:35
Bioventix
-
Result of AGM
10 December 2020 15:03
Bioventix
-
Posting of Annual Report and Notice of AGM
16 November 2020 14:16
Bioventix
-
Holding(s) in Company
27 October 2020 17:27
Bioventix
-
Results for the year ended 30 June 2020
19 October 2020 07:00
Bioventix
-
Holding(s) in Company
20 August 2020 12:37
Bioventix
-
Issue of Equity
8 July 2020 07:00
Bioventix
-
Appointment of CFO
1 July 2020 07:00
Bioventix
-
Appointment of CFO
1 July 2020 07:00
Bioventix
-
Director/PDMR Shareholding
2 April 2020 14:21
Bioventix
-
Correction : Interim Results
31 March 2020 17:47
Bioventix
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.